CAPITOLI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 5.703
EU - Europa 4.719
AS - Asia 4.509
SA - Sud America 712
AF - Africa 88
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 3
Totale 15.748
Nazione #
US - Stati Uniti d'America 5.531
IT - Italia 1.842
SG - Singapore 1.559
CN - Cina 1.006
VN - Vietnam 800
DE - Germania 656
RU - Federazione Russa 620
HK - Hong Kong 613
BR - Brasile 580
IE - Irlanda 366
SE - Svezia 339
GB - Regno Unito 215
AT - Austria 130
CA - Canada 98
FR - Francia 96
ID - Indonesia 95
NL - Olanda 87
FI - Finlandia 83
KR - Corea 83
IN - India 76
JP - Giappone 67
PL - Polonia 58
MX - Messico 56
AR - Argentina 49
UA - Ucraina 45
BD - Bangladesh 39
ZA - Sudafrica 37
TR - Turchia 35
ES - Italia 34
DK - Danimarca 30
EC - Ecuador 21
BE - Belgio 18
LT - Lituania 18
IQ - Iraq 16
VE - Venezuela 14
AU - Australia 13
GR - Grecia 13
PT - Portogallo 13
PY - Paraguay 12
CH - Svizzera 11
SA - Arabia Saudita 11
CZ - Repubblica Ceca 10
EG - Egitto 10
IR - Iran 10
MA - Marocco 10
PK - Pakistan 10
TW - Taiwan 10
UY - Uruguay 10
AE - Emirati Arabi Uniti 9
DZ - Algeria 9
CO - Colombia 8
MY - Malesia 8
PH - Filippine 8
UZ - Uzbekistan 8
BO - Bolivia 7
CL - Cile 7
AZ - Azerbaigian 6
RO - Romania 6
TN - Tunisia 6
JO - Giordania 5
NP - Nepal 5
AL - Albania 4
IL - Israele 4
LB - Libano 4
PE - Perù 4
TH - Thailandia 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
ET - Etiopia 3
JM - Giamaica 3
KE - Kenya 3
KZ - Kazakistan 3
OM - Oman 3
AM - Armenia 2
AO - Angola 2
BB - Barbados 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
EE - Estonia 2
EU - Europa 2
GA - Gabon 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
LV - Lettonia 2
PA - Panama 2
RS - Serbia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TC - Turks e Caicos 2
AX - Isole di terra 1
BH - Bahrain 1
BY - Bielorussia 1
CR - Costa Rica 1
DM - Dominica 1
HN - Honduras 1
IM - Isola di Man 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
Totale 15.732
Città #
Ann Arbor 1.289
Singapore 987
Ashburn 722
Milan 649
Hong Kong 598
Frankfurt am Main 399
Dublin 360
Chandler 274
Ho Chi Minh City 256
Dallas 248
Wilmington 208
Hefei 203
Hanoi 183
New York 176
Los Angeles 174
Santa Clara 172
Beijing 170
Fairfield 156
Dearborn 106
Houston 90
Seoul 81
Princeton 77
Vienna 74
Shanghai 70
Buffalo 69
Jakarta 69
Woodbridge 67
Munich 66
Seattle 64
Cambridge 63
Nuremberg 63
São Paulo 61
Moscow 57
Chicago 49
Rome 47
Caronno Pertusella 42
Warsaw 42
Tokyo 41
Kent 40
Turku 39
Florence 38
Brooklyn 37
Denver 36
London 35
Nanjing 35
Pavia 30
Montreal 27
Cinisello Balsamo 26
Helsinki 26
Toronto 26
Da Nang 25
Monza 25
Naples 25
Atlanta 24
Dong Ket 24
Poplar 24
Coventry 22
Guangzhou 22
Orem 22
Ottawa 22
Boston 21
Haiphong 21
Lissone 21
Mexico City 21
Stockholm 21
Lawrence 20
Fremont 19
The Dalles 19
Altamura 18
Changsha 18
Chennai 18
Jacksonville 18
Sesto San Giovanni 18
Hải Dương 17
Manchester 17
Lappeenranta 16
Melzo 16
Padova 16
Phoenix 16
San Francisco 16
Bergamo 15
Brussels 15
Genoa 15
Ha Long 15
Nanchang 15
Rio de Janeiro 15
Johannesburg 14
Madison 14
Pioltello 14
Romola 14
San Diego 14
Desio 13
Düsseldorf 13
Hebei 13
Bologna 12
Centro Municipality 12
Council Bluffs 12
Istanbul 12
Amsterdam 11
Belo Horizonte 11
Totale 9.788
Nome #
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging 537
In-Depth mapping of the urinary N-glycoproteome: Distinct signatures of ccRCC-related progression 461
Clinical-pathological issues in thyroid pathology: study on the routine application of NIFTP diagnostic criteria 365
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 349
Rendering the invisible visible: adding a molecular dimension to pathology with spatial omics 348
Application of Maldi-imaging proteomics analysis on thyroid biopsies: identification of biomarkers for clinical diagnosis 334
Analysis of Hashimoto's thyroiditis on fine needle aspiration samples by MALDI-Imaging 321
Ex vivo thyroid fine needle aspirations as an alternative for MALDI-MSI proteomic investigation: intra-patient comparison 314
MALDI-MSI as a Complementary Diagnostic Tool in Cytopathology: A Pilot Study for the Characterization of Thyroid Nodules 310
Validation of a skewed surrogate endpoint for a time-to-event outcome: the use of a Zaga distribution 307
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 297
Urinary Extracellular Vesicle Protein Profiles Discriminate Different Clinical Subgroups of Children with Idiopathic Nephrotic Syndrome 287
Spatial resolution of renal amyloid deposits through MALDI-MSI: a combined digital and molecular approach to monoclonal gammopathies 286
BIVARIATE COPULA MODELS IN THE PRESENCE OF COMPLEX PATTERNS FOR THE SURROGATE ENDPOINT FOR A SURVIVAL TRUE ENDPOINT 280
Cytopathology of Bronchoalveolar Lavages in COVID-19 Pneumonia: A Pilot Study 279
Molecular trait of follicular-patterned thyroid neoplasms defined by MALDI-imaging 274
Erratum: Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section (Journal of Proteome Research (2022) 21: 11 (2798−2809) DOI: 10.1021/acs.jproteome.2c00601) 269
Aberrant N-glycosylation patterns related to serum IgG subclasses in Idiopathic membranous nephropathy 257
Cytomolecular Classification of Thyroid Nodules Using Fine-Needle Washes Aspiration Biopsies 242
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 233
Unsupervised neural networks as a support tool for pathology diagnosis in MALDI-MSI experiments: A case study on thyroid biopsies 229
Machine learning streamlines the morphometric characterization and multi-class segmentation of nuclei in different follicular thyroid lesions: everything in a NUTSHELL 227
Diagnostic performances of the acr-tirads system in thyroid nodules triage: A prospective single center study 226
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 223
Iron Overload Following Hematopoietic Stem Cell Transplantation: Prevalence, Severity, and Management in Children and Adolescents with Malignant and Nonmalignant Diseases 220
Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood 218
Thyroid Function Tests in Children and Adolescents with Trisomy 21: Definition of Syndrome-Specific Reference Ranges 218
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 217
Development of new methods for the validation of non standard distributions for the surrogate endpoint for a time to event endpoint. 216
Spatially Resolved Molecular Approaches for the Characterisation of Non-Invasive Follicular Tumours with Papillary-like Features (NIFTPs) 209
Use of diagnostic criteria from acr and eu-tirads systems to improve the performance of cytology in thyroid nodule triage 208
Lights on HBME-1: the elusive biomarker in thyroid cancer pathology 207
Update on: proteome analysis in thyroid pathology - part II: overview of technical and clinical enhancement of proteomic investigation of the thyroid lesions 206
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation 199
Dissecting the histological features of lupus nephritis highlights new common patterns of injury in class III/IV 196
Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section 195
Pubertal attainment and Leydig cell function following pediatric hematopoietic stem cell transplantation: a three-decade longitudinal assessment 194
Advances in clinical proteomics for analysis of fine needle aspiration biopsies: evaluating proteomics stability in preservative solutions 193
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies 193
Progress in clinical applications for the proteomics MALDI Imaging analysis of thyroid fine needle aspiration biopsies 189
DIA-PASEF mass spectrometry as a tailored proteomic approach to explore Idiopathic Membranous Nephropathy 186
Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach 185
FiCoS: A fine-grained and coarse-grained GPU-powered deterministic simulator for biochemical networks 180
A DNA damage response-like phenotype defines a third of colon cancers at onset 172
The routine use of a digital tool for the tumor cell fraction quantification in molecular pathology: an international validation of QuANTUM 170
Precision Nephrology is a Non-Negligible State of Mind In Clinical Research: Remember The Past To Face The Future 170
Progress in clinical applications for the MALDI-imaging analysis of thyroid fine needle aspiration biopsies: evaluation of proteomic stability in preservative solutions 167
Endocrine, auxological and metabolic profile in children and adolescents with Down syndrome: from infancy to the first steps into adult life 166
Limited Knowledge of Toxoplasmosis-Specific Preventive Behaviors in Pregnant Women: A Survey Study in Northern Italy 162
Pelvic ultrasound and pubertal attainment in girls with sexual precocity: the pivotal role of uterine volume in predicting the timing of menarche 160
The management of haemoglobin interference for the MALDI-MSI analysis of in-vivo thyroid biopsies 158
The evolving landscape of diagnostic pathology: a step towards the integration of MALDI-MSI for the routine diagnosis of thyroid fine needle aspiration biopsies 155
Progress in clinical applications for the MALDI-Imaging analysis of thyroid biopsies: evaluation of proteomic stability in preservative solutions 153
The validation of a highly skewed surrogate for a survival endpoint: new approaches 153
Haemochromatosis in children: A national retrospective cohort promoted by the A.I.E.O.P. (Associazione Italiana Emato-Oncologia Pediatrica) study group 151
Image segmentation with Bayesian mixtures models for multiomics MSI analyses 146
Un nuovo approccio basato sull’Imaging con Spettrometria di Massa per la sottotipizzazione dell’amiloidosi renale [A novel mass spectrometry imaging based approach for the subtyping of renal amyloidosisn] 145
Enhancing proteomics characterization of thyroid nodules: a pixel-classifier for mass spectrometry imaging analyses 145
New approaches for the validation of a highly skewed surrogate for a survival endpoint 145
MALDI-MSI as complementary tool in the characterization of thyroid nodules: novelties and challenges in the evolving landscape of diagnostic pathology 141
Plasma proteomic signatures related to COVID-19 disease severity by an untargeted nLC-ESI-MS/MS approach 137
Spatially Resolved Molecular Characterization of Noninvasive Follicular Thyroid Neoplasms with Papillary-like Nuclear Features (NIFTPs) Identifies a Distinct Proteomic Signature Associated with RAS-Mutant Lesions 136
Recent advances in MALDI mass spectrometry imaging: a cutting edge tool for the diagnosis of thyroid nodules 134
Identification of aberrant serum IgG glycoforms in Idiopathic membranous nephropathy 132
Paving the path toward multi-omics approaches in the diagnostic challenges faced in thyroid pathology 129
Reference Values of Ceruloplasmin across the Adult Age Range in a Large Italian Healthy Population 127
Data analysis optimisation of a DIA-PASEF mass spectrometry approach for the study of idiopathic membranous nephropathy disease 126
Reference ranges for complete blood count in children and adolescents with Down syndrome 123
Methods for the validation of a highly skewed continuous surrogate endpoint for a time to event endpoint. 115
Machine Learning for Monoclonal Gammopathies of Renal Significance Risk Stratification Using Clinical and Pathology Data 111
Women's attitude towards COVID-19 vaccination in pregnancy: A survey study in northern Italy 108
Omics in chronic kidney disease: Focus on prognosis and prediction 108
New frontiers in Pathology: MALDI-MS Imaging for diagnosis of thyroid fine needle aspiration biopsies 104
Results of a Multicentre, Randomized, Controlled Open-Label Study on the Use of Anti-T-Lymphocyte Globulin (ATLG) and Rituximab for Immunomodulation of Graft-Versus-Host Disease (GvHD) and Graft Failure (GF) in Patients with Non-Malignant Disorders. 104
Matrix-assisted laser desorption/ionization mass spectrometry imaging as a new tool for molecular histopathology in epilepsy surgery 101
Single-slide detection and typing of AL renal amyloidosis: combining mass spectrometry imaging and digital pathology 97
Does the urinary proteome reflect ccrcc stage and grade progression? 97
Transferrin Saturation and Serum Ferritin Are Main Predictors of Liver Iron Content in Subjects With Hyperferritinemia 91
Machine Learning Ensemble Algorithms for Classification of Thyroid Nodules Through Proteomics: Extending the Method of Shapley Values from Binary to Multi-Class Tasks 86
Spatially Informed Nonnegative Matrix Trifactorization for Coclustering Mass Spectrometry Data 82
Biomarker identification through spatial proteomics for the characterization of indeterminate thyroid nodules 73
Archimedean Copulas: A Useful Approach in Biomedical Data—A Review with an Application in Pediatrics 55
Recent Advances in MALDI Mass Spectrometry Imaging: A Cutting-Edge Tool for the Diagnosis of Thyroid Nodules 53
MiThyCA: A Computational Pathology Pipeline for the Identification of Microscopic Foci of Papillary Thyroid Carcinoma-Like Nuclear Features with AI in Whole-Slide Histological Images 51
Well Begun Is Half Done: The Impact of Pre-Processing in MALDI Mass Spectrometry Imaging Analysis Applied to a Case Study of Thyroid Nodules 16
Assisting clinical diagnosis with interpretable fuzzy probabilistic modelling 14
Totale 16.253
Categoria #
all - tutte 52.056
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.056


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021909 0 0 0 0 0 170 105 138 109 112 108 167
2021/2022953 131 100 95 118 79 69 11 27 43 61 73 146
2022/20231.478 151 317 160 121 79 196 32 122 139 25 66 70
2023/20241.495 55 70 63 114 132 374 274 60 73 40 98 142
2024/20253.912 133 270 322 201 298 197 264 133 420 618 415 641
2025/20265.680 1.263 852 911 1.420 1.189 45 0 0 0 0 0 0
Totale 16.253